You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
江中藥業(600750.SH):遭棄購32.8697萬股 全部由主承銷商包銷
格隆匯 05-31 21:47

格隆匯5月31日丨江中藥業(600750.SH)發佈首次公開發行股票發行結果公吿,保薦機構(主承銷商)根據上海證券交易所和中國結算上海分公司提供的數據,對本次網上、網下發行的新股認購情況進行了統計,結果如下:

(1)網上新股認購情況

網上投資者繳款認購142,554,535股,繳款認購的金額合計為2,248,085,016.95元;網上投資者放棄認購326,465股,放棄認購金額合計為5,148,353.05元。

(2)網下新股認購情況

網下投資者繳款認購15,872,324股,繳款認購的金額合計為250,306,549.48元;網下投資者放棄認購2,232 股,放棄認購金額合計為35,198.64元。

根據《證券發行與承銷管理辦法》(證監會令﹝第144號﹞)、《首次公開發行股票並上市管理辦法》(證監會令﹝第173號﹞)、《首次公開發行股票承銷業務規範》(中證協發﹝2018﹞142號)、《首次公開發行股票配售細則》(中證協發﹝2018﹞142號),網上、網下投資者放棄認購股數全部由保薦機構(主承銷商)包銷,保薦機構(主承銷商)包銷股份的數量為328,697股,包銷金額為5,183,551.69元,保薦機構(主承銷商)包銷比例為0.21%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account